What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Cytokine
His main research concerns Pathology, Cornea, Immunology, Ophthalmology and Eye disease.
His Pathology research includes themes of Proinflammatory cytokine, Meibomian gland and Dry Eye Syndromes.
His Cornea research incorporates themes from Contact lens and Keratitis.
Immunology is often connected to Molecular biology in his work.
He studies Ophthalmology, namely Schirmer test.
His Eye disease research integrates issues from Corneal topography, Visual acuity, Artificial tears and Intraocular pressure.
His most cited work include:
- The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007) (2146 citations)
- The Pathology of Dry Eye: The Interaction Between the Ocular Surface and Lacrimal Glands (654 citations)
- Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. (578 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Ophthalmology, Cell biology, Pathology and Molecular biology are his primary areas of study.
His Immunology study frequently draws connections to adjacent fields such as Ocular surface.
His work deals with themes such as Tears and Surgery, which intersect with Ophthalmology.
He works mostly in the field of Tears, limiting it down to topics relating to Meibomian gland and, in certain cases, Dermatology.
His work on Pathology is being expanded to include thematically relevant topics such as Dry Eye Syndromes.
He combines subjects such as Corneal epithelium, Epithelium and Matrix metalloproteinase with his study of Molecular biology.
He most often published in these fields:
- Immunology (27.29%)
- Ophthalmology (19.03%)
- Cell biology (15.62%)
What were the highlights of his more recent work (between 2016-2021)?
- Immunology (27.29%)
- Conjunctiva (11.67%)
- Goblet cell (7.90%)
In recent papers he was focusing on the following fields of study:
Stephen C. Pflugfelder spends much of his time researching Immunology, Conjunctiva, Goblet cell, Ophthalmology and Inflammation.
His Immunology study combines topics from a wide range of disciplines, such as Commensalism, Lacrimal gland and Lifitegrast.
As a part of the same scientific family, Stephen C. Pflugfelder mostly works in the field of Conjunctiva, focusing on Molecular biology and, on occasion, Retinoic acid.
His research in Goblet cell tackles topics such as Immune system which are related to areas like Dry Eye Syndromes.
Stephen C. Pflugfelder has included themes like Tears, Irritation and Nerve growth factor in his Ophthalmology study.
His research in Inflammation intersects with topics in Acquired immune system, Autophagy, Cytokine and Cell biology.
Between 2016 and 2021, his most popular works were:
- The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research (108 citations)
- LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease (44 citations)
- Goblet Cells Contribute to Ocular Surface Immune Tolerance-Implications for Dry Eye Disease. (43 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Cytokine
Stephen C. Pflugfelder mostly deals with Immunology, Goblet cell, Inflammation, Conjunctiva and Ophthalmology.
His Immunology research includes elements of Lacrimal gland and Lifitegrast.
His Goblet cell study combines topics in areas such as IL-2 receptor, Immune tolerance, Antigen, Degranulation and FOXP3.
His studies in Inflammation integrate themes in fields like Acquired immune system, Cytokine and EBI3.
His research integrates issues of CD86 and Antigen-presenting cell in his study of Conjunctiva.
His work carried out in the field of Ophthalmology brings together such families of science as Randomized controlled trial and Hydrogel scaffold.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
